ArcovaarcovaSignals
Sign inStart for free
Arcova Signals

This week in life science GTM.

A short, curated read of what happened across the industry this week: FDA approvals, clinical trial milestones, funding rounds, grants, and deals. Pulled from public industry data, not personalized to any one company or account.

Week of Sep 28 - Oct 4, 2026 (still being assembled)

Browse the full archive →

In the news this week

  • Sagimet Biosciences Inc. · IPO / follow-on offering · Oct 1, 2026
  • Immix Biopharma · IPO / follow-on offering · Sep 30, 2026
  • Surrozen · Clinical trial phase transition · Oct 2, 2026
  • Biosplice · Clinical trial phase transition · Oct 2, 2026
  • PolyPid · Clinical trial phase transition · Oct 1, 2026
HomeResourcesArcova SignalsCompareHelp centerPrivacyTermsContact
© 2026 Arcova. All rights reserved.
ViroMissile, Inc.
· Clinical trial phase transition · Oct 1, 2026
  • Aktis Oncology, Inc. · Clinical trial phase transition · Oct 1, 2026
  • Abogen Biosciences · Licensing deal · Oct 2, 2026
  • Get the weekly read in your inbox

    One short email a week on what moved across the life science industry. No spam, unsubscribe any time.

    About Arcova Signals. A weekly read of notable biotech and pharma activity, drawn from public industry data. It is not personalized and does not reflect any one customer's accounts. Browse every past issue.
    Free preview

    See this for your own market

    Arcova ranks these same kinds of signals against your specific ICP, not just the industry headlines. Enter your company domain, free, no login required.

    No login requiredTry it free →